{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T07:34:34Z","timestamp":1763105674513},"reference-count":26,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2019]]},"DOI":"10.3960\/jslrt.19025","type":"journal-article","created":{"date-parts":[[2019,12,21]],"date-time":"2019-12-21T22:04:05Z","timestamp":1576965845000},"page":"196-201","source":"Crossref","is-referenced-by-count":2,"title":["Gamma heavy chain disease (\u03b3-HCD) as iatrogenic immunodeficiency- associated lymphoproliferative disorder: Possible emergent subtype of rheumatoid arthritis-associated \u03b3-HCD"],"prefix":"10.3960","volume":"59","author":[{"given":"Hiroko","family":"Tsunemine","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuriko","family":"Zushi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taiichi","family":"Kodaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Franklin EC, Lowenstein J, Bigelow B, Meltzer M. Heavy chain disease\u2014A new disorder of serum \u03b3-globulins. Am J Med. 1964; 37: 332-350.","DOI":"10.1016\/0002-9343(64)90191-3"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Osserman EF, Takatsuki K. Clinical and immunochemical studies of four cases of heavy (H\u03b32) chain disease. Am J Med. 1964; 37: 351-373.","DOI":"10.1016\/0002-9343(64)90192-5"},{"key":"3","unstructured":"3 Fermand JP, Brouet JC, Danon F, Seligmann M. Gamma heavy chain \u201cdisease\u201d: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature. Medicine (Baltimore). 1989; 68: 321-335."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Wahner-Roedler DL, Kyle RA. Heavy chain diseases. Best Pract Res Clin Haematol. 2005; 18: 729-746.","DOI":"10.1016\/j.beha.2005.01.029"},{"key":"5","unstructured":"5 Cook JR, Harris NL, Isaacson PG, Jaffe ES. Heavy chain diseases. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC, World Health Organization. 2017; pp. 237-240."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Wahner-Roedler DL, Witzig TE, Loehrer LL, Kyle RA. Gamma-heavy chain disease: review of 23 cases. Medicine (Baltimore). 2003; 82: 236-250.","DOI":"10.1097\/01.md.0000085058.63483.7f"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Bieliauskas S, Tubbs RR, Bacon CM <i>et al.<\/i> Gamma heavy-chain disease: defining the spectrum of associated lymphoproliferative disorders through analysis of 13 cases. Am J Surg Pathol. 2012; 36: 534-543.","DOI":"10.1097\/PAS.0b013e318240590a"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Husby G, Blichfeldt P, Brinch L <i>et al.<\/i> Chronic arthritis and gamma heavy chain disease: coincidence or pathogenic link? Scand J Rheumatol. 1998; 27: 257-264.","DOI":"10.1080\/030097498442361"},{"key":"9","unstructured":"9 Gaulard P, Swerdlow SH, Harris NL, Sundstr\u00f6m C, Jaffe ES. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC, World Health Organization. 2017; pp. 462-464."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Munshi NC, Digumarthy S, Rahemtullah A. Case 13-2008. N Engl J Med. 2008; 358: 1838-1848.","DOI":"10.1056\/NEJMcpc0800959"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Kiyasu J, Arakawa F, Haji S <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorders with angioimmunoblastic T-cell lymphoma-like features accompanied by gamma-heavy chain disease in a patient with rheumatoid arthritis. Pathol Int. 2018; 68: 485-490.","DOI":"10.1111\/pin.12703"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ito K, Shimizu N, Watanabe K <i>et al.<\/i> Analysis of viral infection by multiplex polymerase chain reaction assays in patients with liver dysfunction. Intern Med. 2013; 52: 201-211.","DOI":"10.2169\/internalmedicine.52.8206"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Zawadzki ZA, Benedek TG, Ein D, Easton JM. Rheumatoid arthritis terminating in heavy-chain disease. Ann Intern Med. 1969; 70: 335-347.","DOI":"10.7326\/0003-4819-70-2-335"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Kretschmer RR, Pizzuto J, Gonz\u00e1lez Ll J, L\u00f3pez M. Heavy chain disease, rheumatoid arthritis and cryoglobulinemia. Clin Immunol Immunopathol. 1974; 2: 195-215.","DOI":"10.1016\/0090-1229(74)90039-7"},{"key":"15","unstructured":"15 Gaucher A, Bertrand F, Brouet JC <i>et al.<\/i> [Gamma heavy chain disease associated with rheumatoid arthritis. Spontaneous disappearance of the pathologic protein]. Sem Hop. 1977; 53: 2117-2120 [in French with English abstract]."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Ockhuizen T, Smit JW, van Leeuwen M. Rheumatoid arthritis associated with transient gamma 2-heavy chain disease. Rheumatol Int. 1983; 3: 167-172.","DOI":"10.1007\/BF00541596"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 St\u00fchlinger W, Berek K, Lapin A, Jaschke E, Pastner D. [Gamma 1 heavy chain disease with immune vasculitis and rheumatoid arthritis]. Klin Wochenschr. 1987; 65: 359-368 [in Germany with English abstract].","DOI":"10.1007\/BF01745573"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Dickson JR, Harth M, Bell DA, Komar R, Chodirker WB. Gamma heavy chain disease and rheumatoid arthritis. Semin Arthritis Rheum. 1989; 18: 247-251.","DOI":"10.1016\/0049-0172(89)90045-0"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Takatani T, Morita K, Takaoka N <i>et al.<\/i> Heavy chain disease screening showing a discrepancy between electrophoretic and nephelometric determinations of serum globulin concentration. Ann Clin Biochem. 2002; 39: 531-533.","DOI":"10.1258\/000456302320314601"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Johannis W, Blommer J, Klatt AR, Renno JH, Wielckens K. Gamma heavy chain disease in a patient with rheumatoid arthritis \u2013 a laboratory evaluation. Biochem Med (Zagreb). 2012; 22: 373-379.","DOI":"10.11613\/BM.2012.039"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Chau CM, Zhang XY, McMahon SB, Lieberman PM. Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. J Virol. 2006; 80: 5723-5732.","DOI":"10.1128\/JVI.00025-06"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Lin P, Molina TJ, Cook JR, Swerdlow SH. Lymphoplasmacytic lymphoma and other non-marginal zone lymphomas with plasmacytic differentiation. Am J Clin Pathol. 2011; 136: 195-210.","DOI":"10.1309\/AJCP8FOIVTB6LBER"},{"key":"23","unstructured":"23 Swerdlow SH, Cook JR, Sohani AR, et al. Lymphoplasmacytic lymphoma. In: Swerdlow SH, Campo E, Harris NL, <i>et al<\/i>. (eds): WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC, World Health Organization. 2017; pp. 232-235."},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Dojcinov SD, Venkataraman G, Pittaluga S <i>et al.<\/i> Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. Blood. 2011; 117: 4726-4735.","DOI":"10.1182\/blood-2010-12-323238"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 W\u00f6rner S, Mueller-Hermelink HK, Voelker HU. Clinicopathologic features of adult EBV-associated B-cell lymphoproliferative disease. Pathol Res Pract. 2018; 214: 207-212.","DOI":"10.1016\/j.prp.2017.11.021"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Zushi Y, Sasaki M, Saitoh T <i>et al.<\/i> Gamma-heavy chain monoclonal gammopathy with undetermined significance (MGUS). J Clin Exp Hematop. 2019; 59: 119-123.","DOI":"10.3960\/jslrt.19008"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/59\/4\/59_19025\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,28]],"date-time":"2019-12-28T04:34:40Z","timestamp":1577507680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/59\/4\/59_19025\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.19025","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]}}}